EUR 3.11
(0.32%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 629 Million EUR | -10.82% |
2022 | 705.28 Million EUR | 24.69% |
2021 | 565.63 Million EUR | 221.79% |
2020 | 175.77 Million EUR | 99.65% |
2019 | 88.04 Million EUR | 63.97% |
2018 | 53.69 Million EUR | 33.58% |
2017 | 40.19 Million EUR | 31.5% |
2016 | 30.56 Million EUR | 17.14% |
2015 | 26.09 Million EUR | 33.62% |
2014 | 19.52 Million EUR | 3.49% |
2013 | 18.87 Million EUR | 3.16% |
2012 | 18.29 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 603.06 Million EUR | 0.0% |
2024 Q1 | 603.06 Million EUR | -4.12% |
2023 Q3 | 629 Million EUR | -9.56% |
2023 FY | 629 Million EUR | -10.82% |
2023 Q1 | 695.47 Million EUR | -1.39% |
2023 Q4 | 629 Million EUR | 0.0% |
2023 Q2 | 695.47 Million EUR | 0.0% |
2022 Q1 | 697.1 Million EUR | 23.24% |
2022 FY | 705.28 Million EUR | 24.69% |
2022 Q4 | 705.28 Million EUR | 0.18% |
2022 Q3 | 704.04 Million EUR | 1.0% |
2022 Q2 | 697.1 Million EUR | 0.0% |
2021 Q4 | 565.63 Million EUR | 0.0% |
2021 Q1 | 556.52 Million EUR | 216.61% |
2021 FY | 565.63 Million EUR | 221.79% |
2021 Q2 | 556.52 Million EUR | 0.0% |
2021 Q3 | 565.63 Million EUR | 1.64% |
2020 Q2 | 90.6 Million EUR | 0.0% |
2020 Q4 | 175.77 Million EUR | -2.87% |
2020 Q1 | 90.6 Million EUR | 2.91% |
2020 FY | 175.77 Million EUR | 99.65% |
2020 Q3 | 180.97 Million EUR | 99.73% |
2019 FY | 88.04 Million EUR | 63.97% |
2019 Q2 | 60.04 Million EUR | 0.0% |
2019 Q4 | 88.04 Million EUR | 0.0% |
2019 Q3 | 88.04 Million EUR | 46.63% |
2019 Q1 | 60.04 Million EUR | 11.83% |
2018 Q4 | 53.69 Million EUR | 0.0% |
2018 FY | 53.69 Million EUR | 33.58% |
2018 Q2 | 37.52 Million EUR | 0.0% |
2018 Q1 | 37.52 Million EUR | -6.64% |
2018 Q3 | 53.69 Million EUR | 43.07% |
2017 FY | 40.19 Million EUR | 31.5% |
2017 Q4 | 40.19 Million EUR | -0.95% |
2017 Q3 | 40.58 Million EUR | 33.32% |
2017 Q2 | 30.44 Million EUR | 0.0% |
2017 Q1 | 30.44 Million EUR | -0.42% |
2016 Q2 | 15.5 Million EUR | -39.01% |
2016 Q1 | 25.41 Million EUR | 0.0% |
2016 FY | 30.56 Million EUR | 17.14% |
2016 Q4 | 30.56 Million EUR | 0.0% |
2016 Q3 | 30.56 Million EUR | 97.21% |
2015 FY | 26.09 Million EUR | 33.62% |
2014 FY | 19.52 Million EUR | 3.49% |
2013 FY | 18.87 Million EUR | 3.16% |
2012 FY | 18.29 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Biotechnologies Assets SA | 16.6 Million EUR | -3687.485% |
Pharma Mar, S.A. | 341.22 Million EUR | -84.337% |
Laboratorios Farmaceuticos Rovi, S.A. | 799.88 Million EUR | 21.363% |